Aflibercept 21mg/184microlitres solution for injection pre-filled syringes
NHS hospitals in England used £90,909,573 of indicative cost of Aflibercept 21mg/184microlitres solution for injection pre-filled syringes in the 12 months to July 2026, about 0.3% of all hospital medicines spend. That is up 177.2% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Aflibercept 21mg/184microlitres solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Aflibercept 21mg/184microlitres solution for injection pre-filled syringes most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Somerset P/Ship Nhs Foundation Trust | £5,977,022 |
| University Hpls Of Leicester Nhs Trust | £5,973,030 |
| South Tyneside And Sunderland Nhs Ft | £5,406,166 |
| Imperial College Healthcare Nhs Trust | £4,825,330 |
| Harrogate & District Foundation Trust | £4,807,366 |
| East Sussex Healthcare Nhs Trust | £3,844,296 |
| United Lincolnshire Hospitals Nhs Trust | £3,433,120 |
| Moorfields Eye Hospital Nhs Ft | £3,353,280 |
| Univ Hpls Bristol Nhs Foundation Trust | £3,351,284 |
| University Hospitals Dorset Nhs Ft | £2,690,608 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.